These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2844402)

  • 21. Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin.
    Reubi JC; Läderach U; Waser B; Gebbers JO; Robberecht P; Laissue JA
    Cancer Res; 2000 Jun; 60(11):3105-12. PubMed ID: 10850463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The vasoactive intestinal peptide (VIP) receptor: recent data and hypothesis.
    Luis J; Martin JM; el Battari A; Marvaldi J; Pichon J
    Biochimie; 1988 Oct; 70(10):1311-22. PubMed ID: 2852963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vasoactive intestinal peptide- and adrenocorticotropin-stimulated adenyl cyclase in cultured adrenal tumor cells: evidence for a specific vasoactive intestinal peptide receptor.
    Birnbaum RS; Alfonzo M; Kowal J
    Endocrinology; 1980 Apr; 106(4):1270-5. PubMed ID: 6244149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of novel splice variants of the PAC1 receptor in human neuroblastoma cells: consequences for signaling by VIP and PACAP.
    Lutz EM; Ronaldson E; Shaw P; Johnson MS; Holland PJ; Mitchell R
    Mol Cell Neurosci; 2006 Feb; 31(2):193-209. PubMed ID: 16226889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Study of species specificity in growth hormone-releasing factor (GRF) interaction with vasoactive intestinal peptide (VIP) receptors using GRF and intestinal VIP receptors from rat and human: evidence that Ac-Tyr1hGRF is a competitive VIP antagonist in the rat.
    Laburthe M; Couvineau A; Rouyer-Fessard C
    Mol Pharmacol; 1986 Jan; 29(1):23-7. PubMed ID: 3003561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The vasoactive intestinal peptide receptor-effector system is developmentally regulated in rat jejuno-ileal epithelial cells.
    Fernandez-Moreno MD; Diaz-Juarez JL; Fernandez-Gonzalez MA; Sanchez-Franco F; Prieto JC
    Biochem Int; 1988 Feb; 16(2):331-7. PubMed ID: 2835052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Solubilization of the active vasoactive intestinal peptide receptor from human colonic adenocarcinoma cells.
    el Battari A; Martin JM; Luis J; Pouzol O; Secchi J; Marvaldi J; Pichon J
    J Biol Chem; 1988 Nov; 263(33):17685-9. PubMed ID: 2846575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serine 447 in the carboxyl tail of human VPAC1 receptor is crucial for agonist-induced desensitization but not internalization of the receptor.
    Marie JC; Rouyer-Fessard C; Couvineau A; Nicole P; Devaud H; El Benna J; Laburthe M
    Mol Pharmacol; 2003 Dec; 64(6):1565-74. PubMed ID: 14645688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for a direct interaction between the Thr11 residue of vasoactive intestinal polypeptide and Tyr184 located in the first extracellular loop of the VPAC2 receptor.
    Nachtergael I; Vertongen P; Langer I; Perret J; Robberecht P; Waelbroeck M
    Biochem J; 2003 Mar; 370(Pt 3):1003-9. PubMed ID: 12475394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunocytochemical identification of VPAC1, VPAC2, and PAC1 receptors in normal and neoplastic human tissues with subtype-specific antibodies.
    Schulz S; Röcken C; Mawrin C; Weise W; Höllt V; Schulz S
    Clin Cancer Res; 2004 Dec; 10(24):8235-42. PubMed ID: 15623599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization and expression of different pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptors in rat ovarian follicles.
    Vaccari S; Latini S; Barberi M; Teti A; Stefanini M; Canipari R
    J Endocrinol; 2006 Oct; 191(1):287-99. PubMed ID: 17065411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in the goose cerebral cortex.
    Zawilska JB; Niewiadomski P; Nowak JZ
    Pol J Pharmacol; 2004; 56(2):203-11. PubMed ID: 15156071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gs and Gq/11 couple vasoactive intestinal peptide and cholinergic stimulation to lacrimal secretion.
    Meneray MA; Fields TY; Bennett DJ
    Invest Ophthalmol Vis Sci; 1997 May; 38(6):1261-70. PubMed ID: 9152245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A fragment of vasoactive intestinal peptide, VIP(10-28), is an antagonist of VIP in the colon carcinoma cell line, HT29.
    Turner JT; Jones SB; Bylund DB
    Peptides; 1986; 7(5):849-54. PubMed ID: 3025826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of nuclear receptors for VIP on a human colonic adenocarcinoma cell line.
    Omary MB; Kagnoff MF
    Science; 1987 Dec; 238(4833):1578-81. PubMed ID: 2825352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Covalent cross-linking of vasoactive intestinal peptide (VIP) to its receptor in intact colonic adenocarcinoma cells in culture (HT 29).
    Muller JM; Luis J; Fantini J; Abadie B; Giannellini F; Marvaldi J; Pichon J
    Eur J Biochem; 1985 Sep; 151(2):411-7. PubMed ID: 2992966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Inhibition by VIP of the proliferation of pancreatic cancer cells].
    Yao CZ
    Zhonghua Wai Ke Za Zhi; 1989 Jan; 27(1):42-4, 62. PubMed ID: 2550185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Processing of vasoactive intestinal peptide and transferrin in human cancerous colonic cells.
    Phan HH; Barakat A; Lefevre C; Boissard C; Rosselin G
    Peptides; 1992; 13(1):53-61. PubMed ID: 1320267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional VIP receptors in the human mucus-secreting colonic epithelial cell line CL.16E.
    Laburthe M; Augeron C; Rouyer-Fessard C; Roumagnac I; Maoret JJ; Grasset E; Laboisse C
    Am J Physiol; 1989 Mar; 256(3 Pt 1):G443-50. PubMed ID: 2538074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of vasoactive intestinal peptide-responsive adenylate cyclase during enterocytic differentiation of Caco-2 cells in culture. Evidence for an increased receptor level.
    Laburthe M; Rousset M; Rouyer-Fessard C; Couvineau A; Chantret I; Chevalier G; Zweibaum A
    J Biol Chem; 1987 Jul; 262(21):10180-4. PubMed ID: 3038870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.